Wegovy pills: A complete guide to the new oral GLP-1

GLP-1s have changed the way the world thinks about weight management. For many women, though, the idea of a weekly injection has been a barrier between them and starting treatment. The new Wegovy tablet changes that.

The first oral GLP-1 pill for weight loss has been approved in the UK by the medicines regulator, meaning there is an opportunity to bring effective treatment to people who could not, or would not, use an injection.

Here is everything you need to know.

What are Wegovy pills and why do they matter?

The new Wegovy tablet contains semaglutide. It is the first oral GLP-1 receptor agonist approved in the US by the FDA to specifically treat obesity. Made by Novo Nordisk, the Wegovy tablet offers a once-daily alternative to the weekly injection. And the good news? Both show comparable results in trials^[1].

Here’s the history: In June 2021, the FDA approved Wegovy injections in the US for weight management^[5]. In September 2023, it was launched in the UK and became available on the NHS for specialist weight management services in line with NICE guidelines. Since then, it has been approved in multiple countries and has been prescribed to millions.

In late 2025, the US medicines regulator (known as the FDA) approved Wegovy tablets as the first oral GLP-1 for weight loss alone^[5]. The UK regulator, the MHRA, has now followed suit by greenlighting the Wegovy pill for weight management^[9]. The first pills will become available in the UK through private providers like Juniper in July 2026. It’s not yet clear if the NHS will offer Wegovy pills.

The pill version opens the door for adults with obesity who want the benefits of the treatment but feel more comfortable with an oral medication rather than an injection. For many women, the difference matters. Injections can sometimes feel intimidating, medical or simply unrealistic. A tablet can feel more familiar and discreet.

How do Wegovy pills work in the body?

GLP-1 (glucagon-like peptide-1) is a natural hormone that your body releases after eating [6]. It signals fullness to the brain, slows the rate at which the stomach empties, and helps regulate blood sugar after a meal.

Semaglutide, the active ingredient in both Wegovy pills and the Wegovy injection, is a GLP-1 receptor agonist. It mimics the natural hormone and activates the same receptors in your brain and gut^[7]. Together, these effects can support weight loss by:

• Reducing hunger and food cravings
• Increasing feelings of fullness after smaller portions
• Slowing gastric emptying, so food stays in your stomach for longer
• Improving blood sugar control after meals by increasing insulin secretion

Although the oral form delivers semaglutide differently, the way it works is the same. The only difference is how the medication enters your bloodstream.

The challenge with an oral formulation is that semaglutide is a larger peptide molecule, which would typically be broken down by stomach acid before it reaches the bloodstream. Wegovy pills use SNAC (salcaprozate sodium) technology, an absorption enhancer that temporarily protects the semaglutide from stomach acid and helps it pass through the stomach lining^[1].

Dr. Simon Doyle, Juniper GP, puts it simply: "Oral Wegovy works the same as the injectable version, but it is wrapped in special casing to stop it being broken down in stomach acid."

Wegovy pills vs Wegovy injections

Both the pill version and injection contain semaglutide and achieve similar results when used as prescribed^[2]. The differences are practical rather than clinical.

‍

You can switch between the tablet and injection, but it will need to be guided by a clinician. The doses are not directly interchangeable because of different dosing schedules and the way the medicine builds up in the body. A healthcare provider can carefully plan any switch to avoid gaps or overlaps.

Who are the new Wegovy pills for?

Wegovy pills are approved in the UK for weight management in adults, using the same criteria as the Wegovy injection^[9]. You may be eligible if you have:

• A BMI of 30 or more, or
• A BMI of 27 or more alongside at least one weight-related health condition, such as high blood pressure or type 2 diabetes

In some cases, our prescribers can also prescribe off-label to someone with a BMI of 25+, where they consider it clinically appropriate and where the expected benefits of the medication outweigh the risks. 

Your prescriber will review your full health history and any current medications before confirming whether Wegovy pills are right for you.

Who should not take Wegovy pills:

• Anyone with a personal or family history of medullary thyroid carcinoma
• People with Multiple Endocrine Neoplasia syndrome type 2 (MEN2)
• Pregnant or breastfeeding women
• Those with severe stomach problems like gastroparesis
• Anyone with a history of pancreatitis

How to take Wegovy pills (dosing and daily routine)

Like the injections, the Wegovy pill follows a gradual dose titration. This helps to minimise side effects and gives your body time to adjust. The typical treatment plan is^[1]:

Days 1-30: 1.5mg once daily

Days 31-60: 4mg once daily

Days 61-90: 9mg once daily

Days 91 onwards: 25mg once daily

Each tablet should be taken first thing in the morning on an empty stomach. Swallow it whole with no more than 120 ml of plain water (not tea, coffee, or juice).

For best absorption^[1]:

• Wait at least 30 minutes before eating food
• Don’t drink anything else during this 30-minute window
• Don’t take other medications for 30 minutes after taking Wegovy
• Don’t crush, chew, dissolve or split the semaglutide tablet

If you miss a dose, skip it and take your next dose at the usual time the following day. Do not take two tablets at once to make up for a missed dose.

Although this medication requires a consistent daily routine, many people find it manageable once it becomes part of their morning habits.

How effective are Wegovy pills for weight loss?

Most of the evidence for the Wegovy pill comes from the OASIS 4 trial, a 71‑week, double‑blind, randomised, placebo‑controlled trial involving 205 participants with a BMI of 30 or over, without diabetes^[3].

Key weight loss results^[3]:

• Participants taking oral semaglutide lost about 16.6% of their starting body weight at 64 weeks (with full adherence)
• The placebo group lost only about 2.2%
• 28% of people lost 20% or more of their starting weight
• All participants followed a reduced‑calorie diet and increased physical activity

For comparison, once‑weekly Wegovy 2.4 mg injections show about 16.9% mean weight loss in similar trials, suggesting that average weight loss is broadly comparable between the tablet and injection^[4].

Dr. Doyle adds context on how oral Wegovy compares with other oral GLP-1s: "In trials, oral Wegovy achieved similar (~15%) weight loss to injectable (~17%). Orforglipron achieved lower weight loss than injectables when used as the starting medication (~12%), but better than older weight loss pills. Recent trials have also shown it is useful in maintenance for those wanting to switch to a pill."

However, individual results vary. Your experience will depend on:

• Your starting body weight and BMI
• Whether you reach higher doses without intolerable side effects
• How consistently you take the medication and follow lifestyle changes
• Diet quality and physical activity levels
• Genetic factors that influence metabolic health

It is important to remember that clinical trials take place in structured, highly supported environments. Real‑world results may differ, and there are no guaranteed outcomes.

Side effects and safety of Wegovy pills

Because Wegovy pills and injections share the same active ingredient, their safety profiles are very similar. Most of the side effects affect the digestive system and are most noticeable when the dose is increasing.

Common side effects include^[1]:

• Nausea
• Diarrhoea
• Vomiting
• Constipation
• Stomach pain and upset stomach
• Indigestion and bloating
• Runny nose and sore throat

More serious but less common risks^[1]:

• Pancreatitis — seek medical help immediately if you experience severe stomach pain
• Gallbladder problems
• Kidney problems (often linked to dehydration from vomiting or diarrhoea)
• Low blood sugar, especially if combined with insulin or sulfonylureas (know how to treat low blood sugar)
• Serious allergic reaction (rare)
• Vision changes in those with type 2 diabetes
• Increase heart rate
• Stomach problems

Wegovy carries a boxed warning about a potential risk of thyroid C‑cell tumours based on animal studies. It is contraindicated for anyone with a personal or family history of medullary thyroid carcinoma or MEN2. While the risk to humans is not confirmed, it requires careful discussion with a clinician^[1].

Drug interactions

Because Wegovy slows gastric emptying, it can affect how your body absorbs other oral medications, including some contraceptive pills and HRT. Your prescriber may adjust timings or recommend backup contraception.

This information does not replace individual medical advice. You should always discuss the risks and benefits with your GP or an obesity specialist before starting any weight loss injections or tablets.

Cost, access, and availability

Currently you can pre-order Wegovy pills from Juniper at the following prices:

• £154 for 1.5mg doses
• £179 for 4mg doses

All prices include an initial order discount of £60, plus the £20 saving we provide to patients who sign up to one of our 6-month commit and save plans. Pricing of the higher 9mg and 25mg doses will be determined before those doses become available in late July.

In the meantime, you don’t have to wait to get started. Wegovy injections are available from £164 per month.

Find out more about Juniper pricing and what’s included.

When will the Wegovy pill be available in the UK?

The Wegovy pill was approved by the UK medicines regulator, known as the MHRA, on 12th June 2026^[9]. Eligible patients can now pre-order Wegovy pills through private providers like Juniper. Shipping to customers will begin in early July once the manufacturer releases the first pills.

Remember that it is important not to buy “Wegovy pills” from unregulated online sources. These products may be counterfeit, incorrectly dosed, or supplied without proper medical supervision. This can carry serious risks.

In the meantime, our programme already provides eligible women with access to GLP-1 medications, health coaching, and ongoing clinical support, so you don't have to wait to get started.

If you want to find out more about how GLP-1 treatment could help you manage your weight, you can complete an online assessment to check your eligibility.

Frequently asked questions

Can I switch from the Wegovy injection to Wegovy pills?

It is possible to switch, but it needs to be managed by a clinician. Although both medications contain semaglutide, the doses are not directly equivalent as one form is taken daily and the other weekly. If you are interested in the oral form, speak to your prescriber. Do not stop or switch your current prescription without medical supervision.

Can I use Rybelsus instead of Wegovy pills for weight loss?

Rybelsus is an oral semaglutide tablet that is approved for type 2 diabetes, not specifically for weight loss. It uses a lower maximum dose than the Wegovy pill. Some clinicians may consider off‑label use in particular cases, but this is not routine and should never be self‑directed. Do not take someone else’s Rybelsus or buy it online for weight loss purposes without proper medical guidance.

What happens if I can’t stick to the 30-minute fasting window?

Dr. Doyle explains why the timing matters: "Because of the way oral Wegovy is structured, it needs to be taken on an empty stomach to enable absorption. If you don't stick to the 30-minute fasting window, some of the drug won't be absorbed well so you won't get a full dose, and therefore you're not likely to get the full benefits."

Eating food or drinking other liquids too soon after taking the tablet reduces absorption, which may make the medicine less effective. If you find the 30‑minute window difficult to manage regularly, speak to your prescriber. They may suggest practical strategies to build the routine into your morning, or they may recommend switching to the weekly injection instead. Occasional timing slips are common and do not mean you should stop treatment immediately. However, consistency over time does matter for the best results.

Will I gain weight back if I stop taking Wegovy pills?

Data from injectable semaglutide show that many people regain at least some weight after stopping treatment, because the medication is no longer helping to reduce appetite. Long‑term habits built during treatment can make a real difference to how much weight is regained. Obesity is usually a chronic health condition that requires ongoing management. If you are thinking about pausing or stopping treatment, discuss this with your doctor first. You may also want to consider continued support through programmes such as Juniper to help you maintain your progress over the long term.

Image credit: Pexels